ID   EYA2_HUMAN              Reviewed;         538 AA.
AC   O00167; Q5JSW8; Q86U84; Q96CV6; Q96H97; Q99503; Q99812; Q9BWF6;
AC   Q9H4S3; Q9H4S9; Q9NPZ4; Q9UIX7;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 2.
DT   10-MAY-2017, entry version 163.
DE   RecName: Full=Eyes absent homolog 2;
DE            EC=3.1.3.48 {ECO:0000269|PubMed:19351884};
GN   Name=EYA2; Synonyms=EAB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Embryonic brain;
RX   PubMed=9195991; DOI=10.1007/s003359900480;
RA   Duncan M.K., Kos L., Jenkins N.A., Gilbert D.J., Copeland N.G.,
RA   Tomarev S.I.;
RT   "Eyes absent: a gene family found in several metazoan phyla.";
RL   Mamm. Genome 8:479-485(1997).
RN   [2]
RP   ERRATUM.
RA   Duncan M.K., Kos L., Jenkins N.A., Gilbert D.J., Copeland N.G.,
RA   Tomarev S.I.;
RL   Mamm. Genome 8:877-877(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Embryo;
RX   PubMed=9020840; DOI=10.1038/ng0297-157;
RA   Abdelhak S., Kalatzis V., Heilig R., Compain S., Samson D.,
RA   Vincent C., Weil D., Cruaud C., Sahly I., Leibovici M.,
RA   Bitner-Glindzicz M., Francis M., Lacombe D., Vigneron J.,
RA   Charachon R., Boven K., Bedbeder P., van Regemorter N.,
RA   Weissenbach J., Petit C.;
RT   "A human homologue of the Drosophila eyes absent gene underlies
RT   branchio-oto-renal (BOR) syndrome and identifies a novel gene
RT   family.";
RL   Nat. Genet. 15:157-164(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 295-538.
RC   TISSUE=Brain;
RX   PubMed=9049631; DOI=10.1101/gr.7.2.128;
RA   Zimmerman J.E., Bui Q.T., Steingrimsson E., Nagle D.L., Fu W.,
RA   Genin A., Spinner N.B., Copeland N.G., Jenkins N.A., Bucan M.,
RA   Bonini N.M.;
RT   "Cloning and characterization of two vertebrate homologs of the
RT   Drosophila eyes absent gene.";
RL   Genome Res. 7:128-141(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 378-496.
RC   TISSUE=Lens epithelium;
RX   PubMed=9887327; DOI=10.1093/hmg/8.1.11;
RA   Borsani G., DeGrandi A., Ballabio A., Bulfone A., Bernard L.,
RA   Banfi S., Gattuso C., Mariani M., Dixon M., Donnai D., Metcalfe K.,
RA   Winter R., Robertson M., Axton R., Brown A., van Heyningen V.,
RA   Hanson I.;
RT   "EYA4, a novel vertebrate gene related to Drosophila eyes absent.";
RL   Hum. Mol. Genet. 8:11-23(1999).
RN   [9]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH GNAZ AND GNAI2.
RX   PubMed=10906137; DOI=10.1074/jbc.M004577200;
RA   Fan X., Brass L.F., Poncz M., Spitz F., Maire P., Manning D.R.;
RT   "The alpha subunits of Gz and Gi interact with the eyes absent
RT   transcription cofactor Eya2, preventing its interaction with the six
RT   class of homeodomain-containing proteins.";
RL   J. Biol. Chem. 275:32129-32134(2000).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=12500905; DOI=10.1023/A:1020990825644;
RA   Fougerousse F., Durand M., Lopez S., Suel L., Demignon J.,
RA   Thornton C., Ozaki H., Kawakami K., Barbet P., Beckmann J.S.,
RA   Maire P.;
RT   "Six and Eya expression during human somitogenesis and MyoD gene
RT   family activation.";
RL   J. Muscle Res. Cell Motil. 23:255-264(2002).
RN   [11]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SIX1.
RX   PubMed=19497856; DOI=10.1074/jbc.M109.016832;
RA   Patrick A.N., Schiemann B.J., Yang K., Zhao R., Ford H.L.;
RT   "Biochemical and functional characterization of six SIX1 Branchio-oto-
RT   renal syndrome mutations.";
RL   J. Biol. Chem. 284:20781-20790(2009).
RN   [12]
RP   FUNCTION.
RX   PubMed=21706047; DOI=10.1038/onc.2011.259;
RA   Farabaugh S.M., Micalizzi D.S., Jedlicka P., Zhao R., Ford H.L.;
RT   "Eya2 is required to mediate the pro-metastatic functions of Six1 via
RT   the induction of TGF-beta signaling, epithelial-mesenchymal
RT   transition, and cancer stem cell properties.";
RL   Oncogene 31:552-562(2012).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 268-538 IN COMPLEX WITH
RP   MAGNESIUM, FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=19351884; DOI=10.1074/jbc.C900032200;
RA   Krishnan N., Jeong D.G., Jung S.-K., Ryu S.E., Xiao A., Allis C.D.,
RA   Kim S.J., Tonks N.K.;
RT   "Dephosphorylation of the C-terminal tyrosyl residue of the DNA
RT   damage-related histone H2A.X is mediated by the protein phosphatase
RT   eyes absent.";
RL   J. Biol. Chem. 284:16066-16070(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 268-538 IN COMPLEX WITH
RP   MAGNESIUM IONS AND TRANSITION STATE ANALOGS, COFACTOR, AND ACTIVE
RP   SITE.
RX   PubMed=19858093; DOI=10.1096/fj.09-143891;
RA   Jung S.K., Jeong D.G., Chung S.J., Kim J.H., Park B.C., Tonks N.K.,
RA   Ryu S.E., Kim S.J.;
RT   "Crystal structure of ED-Eya2: insight into dual roles as a protein
RT   tyrosine phosphatase and a transcription factor.";
RL   FASEB J. 24:560-569(2010).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.99 ANGSTROMS) OF 253-538 IN COMPLEX WITH
RP   SIX1, FUNCTION, SUBUNIT, AND MUTAGENESIS OF PRO-516 AND ALA-532.
RX   PubMed=23435380; DOI=10.1038/nsmb.2505;
RA   Patrick A.N., Cabrera J.H., Smith A.L., Chen X.S., Ford H.L., Zhao R.;
RT   "Structure-function analyses of the human SIX1-EYA2 complex reveal
RT   insights into metastasis and BOR syndrome.";
RL   Nat. Struct. Mol. Biol. 20:447-453(2013).
CC   -!- FUNCTION: Functions both as protein phosphatase and as
CC       transcriptional coactivator for SIX1, and probably also for SIX2,
CC       SIX4 and SIX5 (PubMed:12500905, PubMed:23435380). Tyrosine
CC       phosphatase that dephosphorylates 'Tyr-142' of histone H2AX
CC       (H2AXY142ph) and promotes efficient DNA repair via the recruitment
CC       of DNA repair complexes containing MDC1. 'Tyr-142' phosphorylation
CC       of histone H2AX plays a central role in DNA repair and acts as a
CC       mark that distinguishes between apoptotic and repair responses to
CC       genotoxic stress (PubMed:19351884). Its function as histone
CC       phosphatase may contribute to its function in transcription
CC       regulation during organogenesis. Plays an important role in
CC       hypaxial muscle development together with SIX1 and DACH2; in this
CC       it is functionally redundant with EYA1 (PubMed:12500905).
CC       {ECO:0000269|PubMed:12500905, ECO:0000269|PubMed:19351884,
CC       ECO:0000269|PubMed:21706047, ECO:0000269|PubMed:23435380}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000269|PubMed:19351884}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:19858093};
CC       Note=Binds 1 Mg(2+) ion per subunit.
CC       {ECO:0000269|PubMed:19858093};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.9 uM for H2AXY142ph {ECO:0000269|PubMed:19351884};
CC         KM=80 uM for H2AXS139ph {ECO:0000269|PubMed:19351884};
CC   -!- SUBUNIT: Interacts with DACH2 and SIX1, and probably with SIX2,
CC       SIX4 and SIX5. Interacts with CAPN8 (By similarity). Interacts
CC       with GNAZ and GNAI2; this precludes interaction with SIX1.
CC       {ECO:0000250, ECO:0000269|PubMed:10906137,
CC       ECO:0000269|PubMed:19351884, ECO:0000269|PubMed:19497856,
CC       ECO:0000269|PubMed:19858093, ECO:0000269|PubMed:23435380}.
CC   -!- INTERACTION:
CC       Q15475:SIX1; NbExp=2; IntAct=EBI-750211, EBI-743675;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10906137,
CC       ECO:0000269|PubMed:12500905}. Nucleus
CC       {ECO:0000269|PubMed:10906137, ECO:0000269|PubMed:12500905,
CC       ECO:0000269|PubMed:19497856}. Note=Retained in the cytoplasm via
CC       interaction with GNAZ and GNAI2 (PubMed:10906137). Interaction
CC       with SIX1, SIX2, SIX4 or SIX5 is required for translocation to the
CC       nucleus (PubMed:10906137, PubMed:12500905).
CC       {ECO:0000269|PubMed:10906137, ECO:0000269|PubMed:12500905}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=1;
CC         IsoId=O00167-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00167-2; Sequence=VSP_001490;
CC       Name=3;
CC         IsoId=O00167-3; Sequence=VSP_001491;
CC   -!- TISSUE SPECIFICITY: Highest expression in muscle with lower levels
CC       in kidney, placenta, pancreas, brain and heart.
CC       {ECO:0000269|PubMed:9195991}.
CC   -!- DEVELOPMENTAL STAGE: At the begin of fourth week of development
CC       detected in cytoplasm of somite cells. Between the sixth and
CC       eighth week of development detected in cytoplasm of limb bud
CC       cells. {ECO:0000269|PubMed:12500905}.
CC   -!- SIMILARITY: Belongs to the HAD-like hydrolase superfamily. EYA
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH13882.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U71207; AAB51120.1; -; mRNA.
DR   EMBL; Y10261; CAA71310.1; -; Genomic_DNA.
DR   EMBL; BT006682; AAP35328.1; -; mRNA.
DR   EMBL; AL049540; CAI23166.1; -; Genomic_DNA.
DR   EMBL; AL121776; CAI23166.1; JOINED; Genomic_DNA.
DR   EMBL; AL359434; CAI23166.1; JOINED; Genomic_DNA.
DR   EMBL; AL022342; CAI23166.1; JOINED; Genomic_DNA.
DR   EMBL; AL121776; CAI42150.1; -; Genomic_DNA.
DR   EMBL; AL049540; CAI42150.1; JOINED; Genomic_DNA.
DR   EMBL; AL359434; CAI42150.1; JOINED; Genomic_DNA.
DR   EMBL; AL022342; CAI42150.1; JOINED; Genomic_DNA.
DR   EMBL; AL359434; CAI40099.1; -; Genomic_DNA.
DR   EMBL; AL049540; CAI40099.1; JOINED; Genomic_DNA.
DR   EMBL; AL121776; CAI40099.1; JOINED; Genomic_DNA.
DR   EMBL; AL022342; CAI40099.1; JOINED; Genomic_DNA.
DR   EMBL; BC000289; AAH00289.2; -; mRNA.
DR   EMBL; BC008803; AAH08803.1; -; mRNA.
DR   EMBL; BC013882; AAH13882.2; ALT_INIT; mRNA.
DR   EMBL; U81601; AAB42065.1; -; mRNA.
DR   EMBL; AJ007992; CAA07815.1; -; mRNA.
DR   CCDS; CCDS13403.1; -. [O00167-1]
DR   CCDS; CCDS54471.1; -. [O00167-3]
DR   RefSeq; NP_005235.3; NM_005244.4. [O00167-1]
DR   RefSeq; NP_742108.2; NM_172110.3. [O00167-3]
DR   UniGene; Hs.472877; -.
DR   UniGene; Hs.722040; -.
DR   UniGene; Hs.722415; -.
DR   UniGene; Hs.722416; -.
DR   PDB; 3GEB; X-ray; 2.40 A; A/B/C/D=268-538.
DR   PDB; 3HB0; X-ray; 2.50 A; A/B/C/D=268-538.
DR   PDB; 3HB1; X-ray; 2.51 A; A/B/C/D=268-538.
DR   PDB; 4EGC; X-ray; 1.99 A; B=253-538.
DR   PDBsum; 3GEB; -.
DR   PDBsum; 3HB0; -.
DR   PDBsum; 3HB1; -.
DR   PDBsum; 4EGC; -.
DR   ProteinModelPortal; O00167; -.
DR   SMR; O00167; -.
DR   BioGrid; 108440; 9.
DR   DIP; DIP-40707N; -.
DR   IntAct; O00167; 30.
DR   MINT; MINT-139839; -.
DR   STRING; 9606.ENSP00000333640; -.
DR   ChEMBL; CHEMBL1293275; -.
DR   DEPOD; O00167; -.
DR   iPTMnet; O00167; -.
DR   PhosphoSitePlus; O00167; -.
DR   BioMuta; EYA2; -.
DR   PaxDb; O00167; -.
DR   PeptideAtlas; O00167; -.
DR   PRIDE; O00167; -.
DR   DNASU; 2139; -.
DR   Ensembl; ENST00000327619; ENSP00000333640; ENSG00000064655. [O00167-1]
DR   Ensembl; ENST00000357410; ENSP00000349986; ENSG00000064655. [O00167-3]
DR   Ensembl; ENST00000497062; ENSP00000417105; ENSG00000064655. [O00167-2]
DR   GeneID; 2139; -.
DR   KEGG; hsa:2139; -.
DR   UCSC; uc002xsm.3; human. [O00167-1]
DR   CTD; 2139; -.
DR   DisGeNET; 2139; -.
DR   GeneCards; EYA2; -.
DR   HGNC; HGNC:3520; EYA2.
DR   HPA; HPA027024; -.
DR   HPA; HPA059291; -.
DR   MIM; 601654; gene.
DR   neXtProt; NX_O00167; -.
DR   OpenTargets; ENSG00000064655; -.
DR   PharmGKB; PA27932; -.
DR   eggNOG; KOG3107; Eukaryota.
DR   eggNOG; ENOG410XT12; LUCA.
DR   GeneTree; ENSGT00390000008860; -.
DR   HOVERGEN; HBG002447; -.
DR   InParanoid; O00167; -.
DR   KO; K17620; -.
DR   OMA; IHSRPNC; -.
DR   OrthoDB; EOG091G04YD; -.
DR   PhylomeDB; O00167; -.
DR   TreeFam; TF319337; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   SABIO-RK; O00167; -.
DR   EvolutionaryTrace; O00167; -.
DR   GeneWiki; EYA2; -.
DR   GenomeRNAi; 2139; -.
DR   PRO; PR:O00167; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000064655; -.
DR   ExpressionAtlas; O00167; baseline and differential.
DR   Genevisible; O00167; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR   GO; GO:0016576; P:histone dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0007501; P:mesodermal cell fate specification; TAS:ProtInc.
DR   GO; GO:0097345; P:mitochondrial outer membrane permeabilization; IEA:Ensembl.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IBA:GO_Central.
DR   GO; GO:0045739; P:positive regulation of DNA repair; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0014706; P:striated muscle tissue development; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR028473; EYA2.
DR   InterPro; IPR006545; EYA_dom.
DR   InterPro; IPR028472; EYA_fam.
DR   InterPro; IPR023214; HAD-like_dom.
DR   PANTHER; PTHR10190; PTHR10190; 1.
DR   PANTHER; PTHR10190:SF22; PTHR10190:SF22; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR01658; EYA-cons_domain; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Chromatin regulator;
KW   Complete proteome; Cytoplasm; Developmental protein; DNA damage;
KW   DNA repair; Hydrolase; Magnesium; Metal-binding; Nucleus;
KW   Polymorphism; Protein phosphatase; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    538       Eyes absent homolog 2.
FT                                /FTId=PRO_0000218646.
FT   ACT_SITE    274    274       Nucleophile.
FT                                {ECO:0000269|PubMed:19858093}.
FT   ACT_SITE    276    276       Proton donor.
FT                                {ECO:0000269|PubMed:19858093}.
FT   METAL       274    274       Magnesium. {ECO:0000269|PubMed:19351884}.
FT   METAL       276    276       Magnesium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:19351884}.
FT   METAL       502    502       Magnesium. {ECO:0000269|PubMed:19351884}.
FT   VAR_SEQ      99    122       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_001490.
FT   VAR_SEQ     401    479       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001491.
FT   VARIANT      83     83       P -> S (in dbSNP:rs2275596).
FT                                /FTId=VAR_048964.
FT   VARIANT     238    238       T -> A (in dbSNP:rs866936).
FT                                /FTId=VAR_048965.
FT   MUTAGEN     516    516       P->R: Strongly reduces SIX1 binding.
FT                                {ECO:0000269|PubMed:23435380}.
FT   MUTAGEN     532    532       A->R: Abolishes interaction with SIX1.
FT                                {ECO:0000269|PubMed:23435380}.
FT   CONFLICT    296    296       K -> E (in Ref. 7; AAB42065).
FT                                {ECO:0000305}.
FT   CONFLICT    361    361       G -> A (in Ref. 4; AAP35328 and 6;
FT                                AAH08803). {ECO:0000305}.
FT   CONFLICT    381    381       A -> S (in Ref. 7; AAB42065).
FT                                {ECO:0000305}.
FT   CONFLICT    419    419       A -> V (in Ref. 8; CAA07815).
FT                                {ECO:0000305}.
FT   CONFLICT    525    525       D -> N (in Ref. 1; AAB51120).
FT                                {ECO:0000305}.
FT   STRAND      269    273       {ECO:0000244|PDB:4EGC}.
FT   TURN        277    279       {ECO:0000244|PDB:4EGC}.
FT   HELIX       283    287       {ECO:0000244|PDB:4EGC}.
FT   HELIX       289    294       {ECO:0000244|PDB:4EGC}.
FT   HELIX       298    319       {ECO:0000244|PDB:4EGC}.
FT   HELIX       322    325       {ECO:0000244|PDB:4EGC}.
FT   HELIX       326    328       {ECO:0000244|PDB:3HB0}.
FT   TURN        333    336       {ECO:0000244|PDB:3GEB}.
FT   HELIX       337    339       {ECO:0000244|PDB:3GEB}.
FT   HELIX       350    352       {ECO:0000244|PDB:4EGC}.
FT   HELIX       374    394       {ECO:0000244|PDB:4EGC}.
FT   HELIX       398    402       {ECO:0000244|PDB:4EGC}.
FT   HELIX       406    420       {ECO:0000244|PDB:4EGC}.
FT   TURN        421    423       {ECO:0000244|PDB:4EGC}.
FT   HELIX       424    436       {ECO:0000244|PDB:4EGC}.
FT   STRAND      441    449       {ECO:0000244|PDB:4EGC}.
FT   HELIX       451    460       {ECO:0000244|PDB:4EGC}.
FT   TURN        464    466       {ECO:0000244|PDB:4EGC}.
FT   HELIX       469    471       {ECO:0000244|PDB:4EGC}.
FT   STRAND      472    474       {ECO:0000244|PDB:4EGC}.
FT   TURN        476    478       {ECO:0000244|PDB:4EGC}.
FT   HELIX       480    491       {ECO:0000244|PDB:4EGC}.
FT   STRAND      493    503       {ECO:0000244|PDB:4EGC}.
FT   HELIX       504    512       {ECO:0000244|PDB:4EGC}.
FT   STRAND      517    519       {ECO:0000244|PDB:4EGC}.
FT   HELIX       523    534       {ECO:0000244|PDB:4EGC}.
SQ   SEQUENCE   538 AA;  59232 MW;  3DBFC31D8BE1E85D CRC64;
     MVELVISPSL TVNSDCLDKL KFNRADAAVW TLSDRQGITK SAPLRVSQLF SRSCPRVLPR
     QPSTAMAAYG QTQYSAGIQQ ATPYTAYPPP AQAYGIPSYS IKTEDSLNHS PGQSGFLSYG
     SSFSTSPTGQ SPYTYQMHGT TGFYQGGNGL GNAAGFGSVH QDYPSYPGFP QSQYPQYYGS
     SYNPPYVPAS SICPSPLSTS TYVLQEASHN VPNQSSESLA GEYNTHNGPS TPAKEGDTDR
     PHRASDGKLR GRSKRSSDPS PAGDNEIERV FVWDLDETII IFHSLLTGTF ASRYGKDTTT
     SVRIGLMMEE MIFNLADTHL FFNDLEDCDQ IHVDDVSSDD NGQDLSTYNF SADGFHSSAP
     GANLCLGSGV HGGVDWMRKL AFRYRRVKEM YNTYKNNVGG LIGTPKRETW LQLRAELEAL
     TDLWLTHSLK ALNLINSRPN CVNVLVTTTQ LIPALAKVLL YGLGSVFPIE NIYSATKTGK
     ESCFERIMQR FGRKAVYVVI GDGVEEEQGA KKHNMPFWRI SCHADLEALR HALELEYL
//
